Literature DB >> 16580071

IgE cross-reactivity between the major peanut allergen Ara h 2 and tree nut allergens.

M P de Leon1, A C Drew, I N Glaspole, C Suphioglu, R E O'Hehir, J M Rolland.   

Abstract

Allergy to peanut and tree nuts is characterised by a high frequency of life-threatening anaphylactic reactions and typically lifelong persistence. Although peanut is the most common cause of nut allergy, peanut allergic patients are frequently also sensitive to tree nuts. It is not known if this is due to cross-reactivity between peanut and tree nut allergens. In this study, the major peanut allergen Ara h 2 was cloned from peanut cDNA, expressed in E. coli cells as a His-tag fusion protein and purified using a Ni-NTA column. Immunoblotting, ELISA and basophil activation indicated by CD63 expression all confirmed the IgE reactivity and biological activity of rAra h 2. To determine whether or not this allergen plays a role in IgE cross-reactivity between peanut and tree nuts, inhibition ELISA was performed. Pre-incubation of serum from peanut allergic patients with increasing concentrations of almond or Brazil nut extract inhibited IgE binding to rAra h 2. Purified rAra h 2-specific serum IgE antibodies also bound to proteins present in almond and Brazil nut extracts by immunoblotting. This indicates that the major peanut allergen, Ara h 2, shares common IgE-binding epitopes with almond and Brazil nut allergens, which may contribute to the high incidence of tree nut sensitisation in peanut allergic individuals.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16580071     DOI: 10.1016/j.molimm.2006.02.016

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  18 in total

Review 1.  A comprehensive review of legume allergy.

Authors:  Alok Kumar Verma; Sandeep Kumar; Mukul Das; Premendra D Dwivedi
Journal:  Clin Rev Allergy Immunol       Date:  2013-08       Impact factor: 8.667

2.  Computationally predicted IgE epitopes of walnut allergens contribute to cross-reactivity with peanuts.

Authors:  S J Maleki; S S Teuber; H Cheng; D Chen; S S Comstock; S Ruan; C H Schein
Journal:  Allergy       Date:  2011-08-23       Impact factor: 13.146

3.  In vivo and T cell cross-reactivity between walnut, cashew and peanut.

Authors:  Michael Kulis; Laurent Pons; A Wesley Burks
Journal:  Int Arch Allergy Immunol       Date:  2008-09-19       Impact factor: 2.749

4.  Cross-React: a new structural bioinformatics method for predicting allergen cross-reactivity.

Authors:  Surendra S Negi; Werner Braun
Journal:  Bioinformatics       Date:  2017-04-01       Impact factor: 6.937

5.  Characteristics of tree nut challenges in tree nut allergic and tree nut sensitized individuals.

Authors:  Christopher Couch; Tim Franxman; Matthew Greenhawt
Journal:  Ann Allergy Asthma Immunol       Date:  2017-03-27       Impact factor: 6.347

Review 6.  Impact of thermal processing on legume allergens.

Authors:  Alok Kumar Verma; Sandeep Kumar; Mukul Das; Premendra D Dwivedi
Journal:  Plant Foods Hum Nutr       Date:  2012-12       Impact factor: 3.921

Review 7.  The natural history of peanut and tree nut allergy.

Authors:  David M Fleischer
Journal:  Curr Allergy Asthma Rep       Date:  2007-06       Impact factor: 4.806

Review 8.  The importance of the 2S albumins for allergenicity and cross-reactivity of peanuts, tree nuts, and sesame seeds.

Authors:  Stephen C Dreskin; Stef J Koppelman; Sandra Andorf; Kari C Nadeau; Anjeli Kalra; Werner Braun; Surendra S Negi; Xueni Chen; Catherine H Schein
Journal:  J Allergy Clin Immunol       Date:  2020-11-18       Impact factor: 10.793

9.  Use of animal models to investigate major allergens associated with food allergy.

Authors:  Jenna L Van Gramberg; Michael J de Veer; Robyn E O'Hehir; Els N T Meeusen; Robert J Bischof
Journal:  J Allergy (Cairo)       Date:  2013-04-11

10.  Induction of allergic responses to peanut allergen in sheep.

Authors:  Jenna L Van Gramberg; Michael J de Veer; Robyn E O'Hehir; Els N T Meeusen; Robert J Bischof
Journal:  PLoS One       Date:  2012-12-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.